W2 O Group

21 email addresses found for brewlife.com
{first.l}@brewlife.com
21 email addresses
http://biospace.com/article/releases/bay-area-startup-blackthorn-therapeutics-nabs-another-14-million-bringing-its-series-a-total-to-54-million- November 11, 2017
http://biospace.com/article/releases/orexigen-announces-commercialization-and-distributorship-agreement-with-valeant-for-contrave-naltrexone-hcl-bupropion-hcl-extended-release-in-aust October 10, 2017
http://biospace.com/news/orexigen-announces-commercialization-and/438612 May 5, 2017
http://blackthornrx.com/blackthorn-therapeutics-launches-to-develop-novel-targeted-treatments-for-neurobehavioral-disorders October 10, 2016
http://blackthornrx.com/blackthorn-therapeutics-secures-14-million-in-series-a-extension-financing March 3, 2017
http://businesswire.com/news/home/20151104006704/en/juno-therapeutics-report-quarter-2015-financial-results September 9, 2017
http://businesswire.com/news/home/20160222005536/en/juno-therapeutics-report-full-year-fourth-quarter December 12, 2017
http://businesswire.com/news/home/20160502006020/en/juno-therapeutics-report-quarter-2016-financial-results August 8, 2017
http://businesswire.com/news/home/20170105005612/en/blackthorn-therapeutics-secures-14-million-series-extension September 9, 2017
http://checkorphan.org/news/juno-therapeutics-to-report-third-quarter-2015-financial-results-on-tuesday-november-10 November 11, 2015
http://fiercepharma.com/pharma-asia/orexigen-and-takeda-jointly-announce-orexigen-s-acquisition-of-all-rights-to-contrave-r October 10, 2016
http://firstwordpharma.com/node/1441704 May 5, 2017
http://foxnebraska.com/story/30458119/orexigen-therapeutics-to-present-at-credit-suisse-2015-healthcare-conference November 11, 2015
http://health-fitness.news-articles.net/content/eastern-time-today-discuss-acquisition-rights-contrave-naltrexone-hcl-bupropion-extended-release-central-easte.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/orexigen-announces-strategic-acquisition-all-rights-contrave-market-leading-branded-anti-obesity-prescription-medicine.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/orexigen-takeda-jointly-announce-orexigens-acquisition-all-rights-contrave-the-united-states.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/orexigen-therapeutics-speak-upcoming-investor-conferences.xhtml November 11, 2016
http://ir.orexigen.com/phoenix.zhtml May 5, 2016
http://life-sciences-europe.com/news/juno-presents-morgan-stanley-therapeutics-inc-nasdaq-group-2001-106581.html November 11, 2017
http://prnewswire.com/news-releases/orexigen-announces-strategic-acquisition-of-all-us-rights-to-contrave-the-market-leading-branded-anti-obesity-prescription-medicine-300236042.html May 5, 2017
http://prnewswire.com/news-releases/orexigen-therapeutics-announces-stockholder-approval-of-all-proposals-at-2016-annual-meeting-and-reverse-stock-split-300296025.html July 7, 2017
http://prnewswire.com/news-releases/orexigen-therapeutics-to-present-at-credit-suisse-2015-healthcare-conference-300173855.html March 3, 2017
http://prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2016-financial-results-on-november-3-2016-300348985.html July 7, 2017
http://prnewswire.com/news-releases/orexigen-therapeutics-to-speak-at-the-jp-morgan-2016-global-healthcare-conference-300199538.html October 10, 2016
http://sdbn.org/category/san-diego-biotech-news May 5, 2016
http://sdbn.org/category/san-diego-biotech-news/page/193 August 8, 2017
http://sdbn.org/category/san-diego-biotech-news/page/2 June 6, 2016
http://aol.com/article/2013/08/15/portola-pharmaceuticals-reports-second-quarter-fin/20695490 October 10, 2016
http://aol.com/article/finance/2013/08/15/portola-pharmaceuticals-reports-second-quarter-fin/20695490 July 7, 2017
http://aol.com/article/finance/2013/08/22/diadexus-inc-appoints-ralf-schoenbrunner-to-senior/20701145 July 7, 2017
http://aol.com/article/finance/2013/10/02/diadexus-to-present-at-the-bio-investor-forum/20735659 September 9, 2017
http://aol.com/article/finance/2013/10/15/diadexus-inc-advances-clinical-validation-program-/20745841 September 9, 2017
http://biospace.com/news/avanir-pharmaceuticals-announces-appointment-of/327506 September 9, 2017
http://biospace.com/news/avanir-pharmaceuticals-presents-data-from-a/327446 February 2, 2015
http://biospace.com/News/avanir-pharmaceuticals-presents-data-from-a/327446 May 5, 2015
http://biospace.com/news/portola-pharmaceuticals-inc-announces-two/333658 January 1, 2015
http://cnbc.com/2014/05/12/globe-newswire-portola-pharmaceuticals-to-present-at-bank-of-america-merrill-lynch-2014-health-care-conference.html January 1, 2018
http://cnbc.com/2015/02/24/globe-newswire-portola-pharmaceuticals-to-announce-fourth-quarter-and-year-end-2014-financial-results-and-host-conference-call-on-monday.html January 1, 2018
http://cnbc.com/2015/02/25/globe-newswire-portola-pharmaceuticals-to-present-at-the-cowen-and-company-35th-annual-health-care-conference.html January 1, 2018
http://dailyfinance.com/2013/08/15/portola-pharmaceuticals-reports-second-quarter-fin April 4, 2015
http://globenewswire.com/news-release/2014/01/06/600374/10062908/en/portola-pharmaceuticals-announces-webcast-of-corporate-presentation-on-january-13-2014.html December 12, 2016
http://openhealth.news/content/avanir-pharmaceuticals-presents-data-benchmark-study-pba-symptoms-veterans-mild-traumatic-br October 10, 2017
http://oraclinical.com/articles/portola-pharmaceuticals-announces-collaboration-ora-inc-syk-selective-inhibitor-prt2761 January 1, 2016
http://prnewswire.com/news-releases/avanir-pharmaceuticals-presents-data-from-a-benchmark-study-of-pba-symptoms-in-veterans-with-mild-traumatic-brain-injury-250958051.html January 1, 2015
http://sb08.org/newsroom/index.html October 10, 2016
http://thestreet.com/story/12027352/1/portola-pharmaceuticals-announces-participation-at-upcoming-investor-conferences.html April 4, 2015
http://thestreet.com/story/12089777/1/portola-pharmaceuticals-to-announce-third-quarter-2013-financial-results-and-host-conference-call-on-tuesday-november-5-2013.html May 5, 2015
http://thestreet.com/story/12096842/1/portola-pharmaceuticals-reports-third-quarter-financial-results-and-provides-corporate-update.html September 9, 2017
http://thestreet.com/story/12103773/3/portola-pharmaceuticals-announces-additional-positive-phase-2-proof-of-concept-data-for-andexanet-alfa-prt4445.html January 1, 2015
http://thestreet.com/story/12123803/1/portola-pharmaceuticals-receives-breakthrough-therapy-designation-from-fda-for-andexanet-alfa-prt4445-investigational-factor-xa-inhibitor-antidote.html September 9, 2017
http://aol.com/article/2013/08/02/diadexus-inc-appoints-dr-oye-olukotun-to-board-of-/20685215 June 6, 2017
http://aol.com/article/finance/2013/08/02/diadexus-inc-appoints-dr-oye-olukotun-to-board-of-/20685215 October 10, 2017
http://bio-medicine.org/medicine-technology-1/loxo-oncology-and-array-biopharma-announce-license-and-collaboration-agreement-34174-1 April 4, 2016
http://biospace.com/article/releases/array-biopharma-inc-b-loxo-oncology-b-strike-434-million-cancer-pact- November 11, 2017
http://biospace.com/news/array-biopharma-inc-loxo-oncology-strike-434/302334/source=topbreaking July 7, 2015
http://biospace.com/news/invitae-responds-to-myriad-genetics-inc-lawsuit/317094 January 1, 2015
http://biospace.com/News/invitae-responds-to-myriad-genetics-inc-lawsuit/317094 April 4, 2015
http://businesswire.com/news/home/20140501005459/en/loxo-oncology-initiates-phase-1-trial-loxo October 10, 2016
http://drugs.com/news/portola-enters-into-clinical-collaboration-agreement-bayer-janssen-phase-2-study-universal-factor-42947.html February 2, 2018
http://invitae.com/en/press/invitae-completes-40-million-series-e-financing September 9, 2016
http://invitae.com/en/press/invitae-files-suit-against-myriad-genetics September 9, 2016
http://invitae.com/en/press/invitae-offers-brca1brca2-testing-providing-clinicians-reliable-fast-affordable-option-patients September 9, 2016
http://invitae.com/en/press/invitae-responds-myriad-genetics-lawsuit September 9, 2016
http://ir.invitae.com/news-and-events/press-releases/press-release-details/2013/invitae-completes-40-million-series-e-financing/default.aspx May 5, 2016
http://ir.invitae.com/news-and-events/press-releases/press-release-details/2013/invitae-files-suit-against-myriad-genetics/default.aspx May 5, 2016
http://ir.invitae.com/news-and-events/press-releases/press-release-details/2013/invitae-offers-brca1-brca2-testing-providing-clinicians-with-a-reliable-fast-affordable-option-for-patients/default.aspx May 5, 2016
http://ir.invitae.com/news-and-events/press-releases/press-release-details/2013/invitae-responds-to-myriad-genetics-lawsuit/default.aspx May 5, 2016
http://ir.loxooncology.com August 8, 2017
http://marketwatch.com/story/loxo-oncology-closes-a-24-million-series-b-financing-and-expands-management-team-2014-05-06 July 7, 2015
http://prnewswire.com/news-releases/loxo-oncology-and-array-biopharma-announce-license-and-collaboration-agreement-214880901.html January 1, 2015
http://vcaonline.com/news/news.asp August 8, 2015
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-announces-leadership-transition July 7, 2017
http://aol.com/article/finance/2013/08/19/gtx-reports-results-for-enobosarm-power-trials-for/20697962 September 9, 2017
http://aptusendo.com/news-events/ November 11, 2015
http://avanir.com/press/avanir-pharmaceuticals-announces-appointment-rohan-palekar-president-and-chief-executive February 2, 2016
http://avanir.com/press/avanir-pharmaceuticals-announces-initiation-phase-iii-trial-avp-786-agitation-patients February 2, 2016
http://avanir.com/press/avanir-pharmaceuticals-announces-new-findings-dementiaalzheimers-disease-cohort-prism-ii-study February 2, 2016
http://avanir.com/press/avanir-pharmaceuticals-announces-publication-study-evaluating-prevalence-pseudobulbar-affect February 2, 2016
http://avanir.com/press/avanir-pharmaceuticals-prevails-nuedexta%c2%ae-patent-appeal-maintaining-exclusivity-through-2026 October 10, 2015
http://bio-medicine.org/medicine-technology-1/avanir-pharmaceuticals-announces-results-for-phase-ii-prime-study-37586-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/avanir-pharmaceuticals-reports-fiscal-2013-fourth-quarter-financial-and-year-end-business-results-37587-1 April 4, 2016
http://biospace.com/article/releases/auxogyn-inc-announces-european-expansion-of-new-non-invasive-early-embryo-viability-assessment-eeva-and-0153-test-with-availability-at-first-clini November 11, 2017
http://biospace.com/news/auxogyn-inc-announces-european-expansion-of-new/285604 January 1, 2015
http://biospace.com/news/auxogyn-inc-appoints-womens-health-leader-kathryn/289171 January 1, 2015
http://biospace.com/news/avanir-pharmaceuticals-announces-acceptance-of-new/328316 January 1, 2015
http://biospace.com/news/avanir-pharmaceuticals-crashes-as-multiple/318325 February 2, 2015
http://cnbc.com/2015/07/23/globe-newswire-avalanche-biotechnologies-announces-leadership-transition.html January 1, 2018
http://drugs.com/clinical_trials/avanir-ms-pain-misses-phase-ii-endpoint-16385.html April 4, 2014
http://eei-biotechfinances.com/topica-announces-10-luliconazole-program-ready-for-phase-3-development-for-onychomycosis-based-on-positive-phase-2-results June 6, 2016
http://eei-biotechfinances.com/topica-announces-10-luliconazole-program-ready-for-phase-3-development-for-onychomycosis-based-on-positive-phase-2-results/ November 11, 2015
http://fiercebiotech.com/biotech/avanir-avnr-names-a-new-ceo May 5, 2017
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-announces-leadership-transition September 9, 2017
http://phx.corporate-ir.net/phoenix.zhtml August 8, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-acceptance-of-new-drug-application-for-avp-825-for-the-acute-treatment-of-migraine-252434931.html April 4, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-multiple-data-presentations-related-to-pseudobulbar-affect-pba-prevalence-and-treatment-at-two-conferences-in-june-261235571.html May 5, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-results-for-phase-ii-prime-study-235285861.html January 1, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-submission-of-new-drug-application-for-avp-825-for-the-acute-treatment-of-migraine-242747391.html January 1, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-reports-fiscal-2013-fourth-quarter-financial-and-year-end-business-results-235285871.html April 4, 2015
http://avanir.com/press/avanir-pharmaceuticals-announces-multiple-data-presentations-highlighting-its-central-nervous October 10, 2015
http://avanir.com/press/avanir-pharmaceuticals-announces-presentation-survey-evaluating-prevalence-pseudobulbar-affect February 2, 2016
http://bio-medicine.org/medicine-technology-1/avanir-pharmaceuticals-announces-fda-acceptance-of-ind-for-avp-786-for-the-adjunctive-treatment-of-major-depressive-disorder-38475-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/avanir-pharmaceuticals-announces-initiation-of-phase-ii-study-of-avp-786-for-the-adjunctive-treatment-of-major-depressive-disorder-39511-1 July 7, 2017
http://bio-medicine.org/medicine-technology-1/avanir-pharmaceuticals-announces-presentation-of-positive-early-results-from-prism-ii-study-38374-1 July 7, 2017
http://biospace.com/news/jennerex-inc-completes-21-6-million-private/297717 September 9, 2017
http://biospace.com/news/sequenta-inc-lands-20-million/301697 January 1, 2015
http://biospace.com/news/sequenta-inc-lands-20-million/301697/source=yesterdaysmostpopular January 1, 2015
http://biospace.com/News/sequenta-inc-lands-20-million/301697/Source=YesterdaysMostPopular April 4, 2015
http://bloomberg.com/article/2014-06-24/ax3v6b4kyhyq.html August 8, 2015
http://businesswire.com/news/home/20140610005301/en/mirna-therapeutics-announces-patient-enrolled-hematological-malignancy January 1, 2015
http://businesswire.com/news/home/20150312005247/en/allergen-research-corporation-completes-80-million-series September 9, 2017
http://businesswire.com/news/home/20150713005408/en/dr.-jay-venkatesan-joins-alpine-bioventures-managing September 9, 2017
http://eei-biotechfinances.com/aeglea-biotherapeutics-announces-publication-of-nonclinical-data-on-lead-molecule-aeb1102-in-human-molecular-genetics May 5, 2017
http://eei-biotechfinances.com/aeglea-biotherapeutics-announces-publication-of-nonclinical-data-on-lead-molecule-aeb1102-in-human-molecular-genetics/ November 11, 2015
http://higbio.com/news/release/764 January 1, 2016
http://investor.mirnarx.com February 2, 2016
http://investor.mirnarx.com/alerts.cfm September 9, 2017
http://investor.mirnarx.com/login.cfm September 9, 2017
http://investor.mirnarx.com/sec.cfm September 9, 2017
http://nlvpartners.com/news-january-7-2016-2 March 3, 2016
http://nlvpartners.com/news-january-7-2016-2/ January 1, 2016
http://principiabio.com/news/010716 January 1, 2016
http://principiabio.com/news/061515 January 1, 2016
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-fda-acceptance-of-ind-for-avp-786-for-the-adjunctive-treatment-of-major-depressive-disorder-267930411.html January 1, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-initiation-of-phase-ii-study-of-avp-786-for-the-adjunctive-treatment-of-major-depressive-disorder-272700931.html May 5, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-three-data-presentations-related-to-avp-825-for-the-acute-treatment-of-migraine-at-the-american-headache-society-annual-meeting-264381361.html January 1, 2015
http://prnewswire.com/news-releases/avanir-pharmaceuticals-announces-two-data-presentations-related-to-pseudobulbar-affect-pba-at-the-alzheimers-association-international-conference-aaic-265299061.html January 1, 2015
http://thestreet.com/story/12775697/1/avanir-pharmaceuticals-announces-presentation-of-positive-early-results-from-prism-ii-study.html May 5, 2017
http://thestreet.com/story/12779751/1/avanir-pharmaceuticals-announces-fda-acceptance-of-ind-for-avp-786-for-the-adjunctive-treatment-of-major-depressive-disorder.html July 7, 2017
11 more results for brewlife.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month.

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about brewlife.com

Industry: Internet and Telecom

Language of the website: English

Main technologies used: